Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
57,242
+22,824
+66% +$848K 0.01% 154
2026
Q1
$1.38M Buy
34,418
+15,485
+82% +$733K 0.02% 162
2025
Q4
$851K Sell
18,933
-22,759
-55% -$1.05M 0.02% 137
2025
Q3
$1.86M Sell
41,692
-43,467
-51% -$2.08M 0.05% 94
2025
Q2
$4.09M Sell
85,159
-8,862
-9% -$385K 0.15% 60
2025
Q1
$3.77M Buy
94,021
+52,389
+126% +$2.2M 0.13% 60
2024
Q4
$1.91M Buy
+41,632
New +$1.86M 0.1% 64

Other funds holding QGEN

SIH Partners's QGEN Position: Q2 2026 in Review

SIH Partners increased its Qiagen (QGEN) stake by 66% in Q2 2026, buying an estimated $848K and bringing the position to 57,242 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #154.

SIH Partners first reported a position in QGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.09M in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • SIH Partners held 57,242 shares of Qiagen worth $2.24M as of Q2 2026.
  • SIH Partners bought 22,824 Qiagen shares in Q2 2026, an estimated $848K.
  • Qiagen made up 0.01% of SIH Partners's portfolio in Q2 2026, its #154 holding.
  • SIH Partners first reported a position in Qiagen in Q4 2024 and has held it in 7 quarters since.
  • SIH Partners's Qiagen position peaked at $4.09M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.